The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2015

Filed:

Jul. 06, 2010
Applicants:

Feng-jing Chen, Danbury, CT (US);

Robert J. Schwabe, Stamford, CT (US);

Inventors:

Feng-Jing Chen, Danbury, CT (US);

Robert J. Schwabe, Stamford, CT (US);

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/06 (2006.01); A61K 31/427 (2006.01); A61K 9/107 (2006.01); A61K 9/48 (2006.01); A61K 47/10 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2006.01); A61K 47/44 (2006.01);
U.S. Cl.
CPC ...
A61K 31/427 (2013.01); A61K 9/1075 (2013.01); A61K 9/4858 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/44 (2013.01);
Abstract

Disclosed is a pharmaceutical composition of a hepatitis C viral protease inhibitor which is suitable for oral administration via a liquid- or semi-solid-filled capsule and methods of using this composition for inhibiting the replication of the hepatitis C virus (HCV) and for the treatment of an HCV infection. The liquid- or semi-solid pharmaceutical composition of the present invention comprises a compound of formula I, or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable lipids and hydrophilic surfactants.


Find Patent Forward Citations

Loading…